IBDEI15V ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20791,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,20791,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,20791,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,20792,0)
 ;;=530.81^^131^1296^30
 ;;^UTILITY(U,$J,358.3,20792,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20792,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,20792,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,20792,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,20793,0)
 ;;=389.9^^131^1296^32
 ;;^UTILITY(U,$J,358.3,20793,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20793,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,20793,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,20793,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,20794,0)
 ;;=784.0^^131^1296^31
 ;;^UTILITY(U,$J,358.3,20794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20794,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,20794,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,20794,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,20795,0)
 ;;=070.54^^131^1296^33
 ;;^UTILITY(U,$J,358.3,20795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20795,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,20795,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,20795,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,20796,0)
 ;;=272.4^^131^1296^34
 ;;^UTILITY(U,$J,358.3,20796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20796,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,20796,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,20796,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,20797,0)
 ;;=272.2^^131^1296^35
 ;;^UTILITY(U,$J,358.3,20797,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20797,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,20797,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,20797,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,20798,0)
 ;;=401.9^^131^1296^36
 ;;^UTILITY(U,$J,358.3,20798,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20798,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,20798,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,20798,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,20799,0)
 ;;=244.9^^131^1296^37
 ;;^UTILITY(U,$J,358.3,20799,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20799,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,20799,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,20799,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,20800,0)
 ;;=790.21^^131^1296^38
 ;;^UTILITY(U,$J,358.3,20800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20800,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,20800,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,20800,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,20801,0)
 ;;=790.5^^131^1296^40
 ;;^UTILITY(U,$J,358.3,20801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20801,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,20801,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,20801,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,20802,0)
 ;;=724.2^^131^1296^41
 ;;^UTILITY(U,$J,358.3,20802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20802,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,20802,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,20802,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,20803,0)
 ;;=412.^^131^1296^45
 ;;^UTILITY(U,$J,358.3,20803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20803,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,20803,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,20803,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,20804,0)
 ;;=250.60^^131^1296^47
 ;;^UTILITY(U,$J,358.3,20804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20804,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,20804,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,20804,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,20805,0)
 ;;=V15.81^^131^1296^48
